INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
LT

Leggett Thomas

Chief Financial OfficerCIK 0001774690

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 5
Max Insider Score40
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$1,215
37 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Stoke Therapeutics, Inc.Chief Financial Officer · Mar 19, 2026
39
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL
$68K
2,173 sh
Mar 18, 2026
Mar 19, 2026
traded Mar 18, 2026
+1d
SEC FORM 4

Evidence

40
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$31K
922 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

40
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$42K
1,274 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

32
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$5,468
172 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence